Molecular changes in diabetic foot ulcers. (2011 study) Skip to main content
Clinical Study Diabetes research and clinical practice 2011

Molecular changes in diabetic foot ulcers.

Wang CJ, Ko JY, Kuo YR, Yang YJ, Diabetes research and clinical practice, 2011

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers compared two treatments for long-lasting diabetic foot ulcers, shockwave therapy and hyperbaric oxygen therapy, by taking tissue samples from the ulcer edge before and after treatment.

What They Found

This cohort study of diabetic foot ulcers found that tissue markers of blood vessel growth and regeneration rose significantly after shockwave therapy (ESWT) but not after hyperbaric oxygen therapy (HBOT). The ESWT group had 39 patients (44 ulcers) and received shockwave treatment twice per week for six treatments. The HBOT group had 38 patients (40 ulcers) and received daily hyperbaric oxygen for 20 treatments. After ESWT, vWF, VEGF, eNOS, PCNA and EGF increased and TUNEL decreased (p less than 0.05). After HBOT, the changes were not statistically significant (p greater than 0.05). The two groups were comparable before treatment, and after treatment the differences between groups were statistically significant, favouring ESWT.

What This Means for Canadian Patients

For people with chronic diabetic foot ulcers, this study measured tissue changes in ulcer biopsies and did not report whether ulcers healed. In this study, the tissue markers changed significantly after ESWT but not after HBOT. The abstract does not report healing rates or clinical outcomes, so it cannot show which treatment heals ulcers better.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes a cohort study rather than a randomized trial, so the groups may differ in ways not measured, and it reports tissue markers rather than ulcer healing or other patient outcomes.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Wound Care
Source Pubmed
PubMed ID 21742400
Year Published 2011
Journal Diabetes research and clinical practice
MeSH Terms Diabetic Foot; Epidermal Growth Factor; Female; Humans; Hyperbaric Oxygenation; Immunohistochemistry; Male; Proliferating Cell Nuclear Antigen; Vascular Endothelial Growth Factor A; von Willebrand Factor

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology